AI devices with FDA product code OZE — Influenza A And Influenza B Multiplex Nucleic Acid Assay
Product code OZE (“Influenza A And Influenza B Multiplex Nucleic Acid Assay” in openFDA) covers 1 device on the FDA AI-enabled list, from 1 company. Most are reviewed by the Microbiology panel (1). The most recent decision was FluChip-8G Influenza A+B Assay on April 22, 2019.
1AI devices
1Companies
2019First decision
2019-04-22Latest decision
Trend: devices per year
2019